UK Biotechs Get Share Of £1bn Coronavirus Support Fund
Payments Must Not Be Delayed, Says BIA
Executive Summary
Small-to-medium non-profit making UK biotechs will be supported via loans and grants, but government unmoved by Tax Credits suggestion for whole sector.
You may also be interested in...
UK Biotechs Seek Government Help As Economic ‘Heart Attack’ Threatens Sector
Huge economic shock to sector could be quickly alleviated by early payment of R&D Tax Credits, says BIA.
Vertex’s $5bn Alpine Buyout Builds Autoimmune Disease Presence
The company hopes for a “Humira-like” blockbuster with povetacicept, the object of the sector’s biggest M&A deal so far this year.
AstraZeneca’s Next-Gen PARP Inhibitor Hints At Better Safety And Efficacy In Breast Cancer
Early signs of improved safety and efficacy should set up PARP1 inhibitor for potential combinations and future broader use, but the true extent of its benefits remain to be seen.